mitoxantrone has been researched along with Castleman Disease in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Castleman Disease: Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervigón, I | 1 |
| Palomo, A | 1 |
| Torres-Iglesias, LM | 1 |
| Solano, F | 1 |
| Zapata, AM | 1 |
| Casarotto, D | 1 |
| Bottio, T | 1 |
| Gambino, A | 1 |
| Testolin, L | 1 |
| Gerosa, G | 1 |
1 review available for mitoxantrone and Castleman Disease
| Article | Year |
|---|---|
[Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C | 2011 |
1 other study available for mitoxantrone and Castleman Disease
| Article | Year |
|---|---|
The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiomyopathy, Dilated; Castleman Di | 2003 |